This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Ductal Carcinoma in Situ
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to find molecular signs (biomarkers) to better understand the role of green tea as an anti-cancer and anti-inflammation agent in women with newly-diagnosed ductal carcinoma in situ (DCIS).

Provided treatments

  • Drug: Polyphenon E

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01060345. The sponsor of the trial is University of Chicago and it is looking for 32 volunteers for the current phase.
Official trial title:
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ (DCIS)